US Broker Ratings

AtriCure, Inc. (ATRC) Stock Analysis: A 29% Upside Potential with Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC) stands at the forefront of the healthcare sector, specifically within the medical instruments and supplies industry, where it continues to innovate in the realm of cardiac..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A 27.79% Potential Upside Sparks Investor Interest

BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing the attention of investors with its promising potential..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Navigating a 9.28% Potential Upside with Robust CNS Drug Pipeline

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) continues to capture investor attention with its strategic focus on developing and commercializing treatments for central nervous system (CNS) disorders and rare diseases. Based in..

Recursion Pharmaceuticals (RXRX): Investor Outlook with a 69% Potential Upside

In the bustling world of biotechnology, Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) stands out as a company blending technological prowess with drug discovery to address some of healthcare’s most challenging diseases...

NewAmsterdam Pharma (NAMS) Stock Analysis: Promising 36% Upside Potential Despite Current Challenges

NewAmsterdam Pharma Company N.V. (NAMS), a Netherlands-based biopharmaceutical firm, is drawing significant investor attention thanks to its innovative approach in the biotechnology sector. Specializing in the development of therapies targeting..

Omnicell, Inc. (OMCL): Investor Outlook on a 11.62% Potential Upside in Healthcare Automation

Omnicell, Inc. (NASDAQ: OMCL), a pivotal player in the healthcare automation sector, offers intriguing investment opportunities with a projected potential upside of 11.62%. With a market capitalization of $2.12 billion..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: A Promising 39% Upside Potential Captures Investor Attention

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a key player in the biotechnology sector, is turning heads with a robust growth trajectory and a promising upside potential of 39.05%. With its innovative..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 175% Potential Upside in the Diagnostics & Research Sphere

Opko Health, Inc. (OPK) holds a unique position within the healthcare sector, particularly in the diagnostics and research industry. With its headquarters in Miami, Florida, Opko Health operates a diverse..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Biotechnology Innovator with Nearly 96% Upside Potential

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a key player in the biotechnology sector, is capturing investor attention with its innovative approach in treating retinal diseases and other eye conditions. Despite recent..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Promising 68.80% Upside Potential

Investors with an eye on the biotechnology sector may want to consider Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage company specializing in novel therapeutics for rare endocrine diseases. With a..

BGM Group Ltd. (BGM) Investor Outlook: Navigating a Downturn and Future Prospects

Investors in BGM Group Ltd. (BGM) might be intrigued by its unique position within the healthcare sector, specifically the drug manufacturers – specialty & generic industry in China. With a..

Artivion, Inc. (AORT) Stock Analysis: Unveiling an 11.62% Potential Upside in the Medical Device Sector

Artivion, Inc. (NYSE: AORT) stands out in the healthcare sector with its innovative medical devices and implantable human tissues. Headquartered in Kennesaw, Georgia, Artivion, formerly known as CryoLife, Inc., offers..

Evotec SE (EVO) Stock Analysis: Exploring a 77.69% Potential Upside with a Strong R&D Backbone

Evotec SE (EVO), a prominent player in the healthcare sector, specializes in drug discovery and development with operations spanning across the globe. Based in Hamburg, Germany, Evotec SE is classified..

Merus N.V. (MRUS) Stock Analysis: Exploring a 7.78% Potential Upside in Biotechnology

Merus N.V. (MRUS), a prominent player in the biotechnology industry, offers an intriguing opportunity for investors seeking to navigate the complex landscape of healthcare innovation. Headquartered in Utrecht, Netherlands, Merus..

MiMedx Group, Inc. (MDXG) Stock Analysis: Unveiling a 76% Potential Upside in the Biotech Sector

MiMedx Group, Inc. (NASDAQ: MDXG), a prominent player in the biotechnology sector, is currently capturing investor attention with a potential upside of 76.56%, as indicated by its average target price...

Ardent Health, Inc. (ARDT) Stock Analysis: A 52.53% Potential Upside Amid Healthcare Sector Dynamics

Ardent Health, Inc. (NYSE: ARDT) presents a compelling opportunity for investors seeking value in the healthcare sector, with a standout potential upside of 52.53%. Based in Brentwood, Tennessee, Ardent Health..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare Challenges with a Robust Dividend Yield

Premier, Inc. (NASDAQ: PINC), a key player in the health information services sector, continues to navigate the complexities of the U.S. healthcare industry with a focus on optimizing supply chains..

Catalyst Pharmaceuticals, Inc. (CPRX) Investor Outlook: Unveiling a Promising 44.88% Upside

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a prominent player in the biotechnology sector, is making waves with its strategic focus on rare diseases. Headquartered in Coral Gables, Florida, this commercial-stage biopharmaceutical..

Tarsus Pharmaceuticals (TARS) Investor Outlook: Strong Buy Ratings and Promising Revenue Growth in Biotech

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a trailblazer in the biopharmaceutical sector, is making waves in the healthcare industry with its cutting-edge therapeutic developments. Headquartered in Irvine, California, Tarsus is focused..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring an 8.20% Upside Potential

Healthcare Services Group, Inc. (HCSG), a prominent player in the healthcare sector, is making waves with its significant presence in medical care facilities across the United States. With a current..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds